相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。1-(3′,4′-dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel γ-secretase modulator, reduces brain β-amyloid pathology in a Transgenic mouse model of Alzheimer's disease without causing peripheral toxicity
Bruno P. Imbimbo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-β after inhibition of γ-secretase
Eric R. Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Safety, tolerability, pharmacokinetics, and Aβ levels after short-term administration of R-flurbiprofen in healthy elderly individuals
Douglas R. Galasko et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice
Thomas Kukar et al.
BMC NEUROSCIENCE (2007)
Secretion of the Notch-1 Aβ-like peptide during Notch signaling
M Okochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease
ER Siemers et al.
NEUROLOGY (2006)
γ-Secretase substrate selectivity can be modulated directly via interaction with a nucleotide-binding site
PC Fraering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Evidence that the NF motif in transmembrane domain 4 of presenilin 1 is critical for binding with PEN-2
SH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pen-2 is incorporated into the γ-secretase complex through binding to transmembrane domain 4 of presenilin 1
N Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nicastrin functions as a γ-secretase-substrate receptor
S Shah et al.
CELL (2005)
CD147 is a regulatory subunit of the γ-secretase complex in Alzheimer's disease amyloid β-peptide production
SX Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Safety, tolerability, and changes in amyloid β concentrations after administration of a γ-secretase inhibitor in volunteers
E Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Quantitative measurement of changes in amyloid-β(40) in the rat brain and cerebrospinal fluid following treatment with the γ-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide]
JD Best et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The initial substrate-binding site of γ-secretase is located on presenilin near the active site
AY Kornilova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897
JJ Anderson et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Dynamics of β-amyloid reductions in brain, cerebrospinal fluid, and plasma of β-amyloid precursor protein transgenic mice treated with a γ-secretase inhibitor
DM Barten et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation
GT Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Detergent-dependent dissociation of active γ-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex
PC Fraering et al.
BIOCHEMISTRY (2004)
Purification and characterization of the human γ-secretase complex
PC Fraering et al.
BIOCHEMISTRY (2004)
Discovery of a subnanomolar helical D-tridecapeptide inhibitor of γ-secretase
F Bihel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: identification of nicastrin mutants that selectively interact with APH-1
K Shirotani et al.
JOURNAL OF NEUROCHEMISTRY (2004)
γ-secretase:: proteasome of the membrane?
R Kopan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Selected non-steroidal anti-inflammatory drugs and their derivatives target γ-secretase at a novel site -: Evidence for an allosteric mechanism
D Beher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitor
GH Searfoss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The transmembrane domain region of nicastrin mediates direct interactions with APH-1 and the γ-secretase complex
VA Morais et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Gleevec inhibits β-amyloid production but not Notch cleavage
WJ Netzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Designed helical peptides inhibit an intramembrane protease
C Das et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Assembly of the γ-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin
MJ LaVoie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity
S Weggen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
JL Eriksen et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces Aβ levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice
TA Lanz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
γ-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
WT Kimberly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Different cofactor activities in γ-secretase assembly:: evidence for a nicastrin-Aph-1 subcomplex
Y Hu et al.
JOURNAL OF CELL BIOLOGY (2003)
Differential effects of inhibitors on the γ-secretase complex -: Mechanistic implications
AY Kornilova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reconstitution of γ-secretase activity
D Edbauer et al.
NATURE CELL BIOLOGY (2003)
The role of presenilin cofactors in the γ-secretase complex
N Takasugi et al.
NATURE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
aph-1 and pen-2 are required for notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation
R Francis et al.
DEVELOPMENTAL CELL (2002)
Identification of signal peptide peptidase, a presenilin-type aspartic protease
A Weihofen et al.
SCIENCE (2002)
Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate
WP Esler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos
C Goutte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
HF Dovey et al.
JOURNAL OF NEUROCHEMISTRY (2001)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing
G Yu et al.
NATURE (2000)
Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1
ZH Zhang et al.
NATURE CELL BIOLOGY (2000)
Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells
A Herreman et al.
NATURE CELL BIOLOGY (2000)
Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1
WP Esler et al.
NATURE CELL BIOLOGY (2000)
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
YM Li et al.
NATURE (2000)
分享论文
